SEC Form 4 · accession 0001131096-17-000074
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kane
Director
Period of report
Apr 28, 2017
Accepted (ET)
May 2, 2017 · 7:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2017 | M | 5,000 | $36.67 | A | 14,729 | D | |
| Common Stock | Apr 28, 2017 | M | 5,000 | $36.67 | A | 19,729 | D | |
| Common StockF2 | Apr 28, 2017 | S | 3,700 | $97.58 | D | 16,029 | D | |
| Common StockF3 | Apr 28, 2017 | S | 2,700 | $98.29 | D | 13,329 | D | |
| Common StockF4 | Apr 28, 2017 | S | 3,000 | $99.00 | D | 10,329 | D | |
| Common StockF5 | Apr 28, 2017 | S | 500 | $100.84 | D | 9,829 | D | |
| Common Stock | Apr 28, 2017 | S | 100 | $101.83 | D | 9,729 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $36.67 | Apr 28, 2017 | M | 5,000 | D | Jul 31, 2011 | Aug 2, 2019 | Common Stock | 5,000 | 0 | D |
| Stock Option (Right to Buy) | $36.67 | Apr 28, 2017 | M | 5,000 | D | Aug 1, 2011 | Aug 2, 2019 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person and effective as of February 27, 2017, in accordance with Rule 10b5-1.
- F2Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.96 to $97.95, inclusive.
- F3Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.96 to $98.91, inclusive.
- F4Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.03, inclusive.
- F5Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.71 to $101.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.